Key result
A 55-year-old woman with Graves' hyperthyroidism experienced ventricular fibrillation and was found to have a rare SCN5A mutation (W1191X) associated with Brugada syndrome.
Why the study?
Most thyrotoxicosis-related arrhythmias are supraventricular, making ventricular arrhythmias in the absence of coronary disease or heart failure an unusual manifestation.
Case Report (n=1)
No
Thyrotoxicosis may trigger ventricular fibrillation by lowering the arrhythmia threshold in patients with an underlying genetic predisposition, such as an SCN5A mutation associated with Brugada syndrome.
Thyroid storm may unmask VF risk in SCN5A carriers; this case leaves open whether ECG screening or monitoring is warranted in thyrotoxicosis.
Most thyrotoxicosis-related arrhythmias are supraventricular in origin. Ventricular arrhythmias, in the absence of underlying coronary disease or heart failure, are an unusual manifestation of thyrotoxicosis. We report a case of ventricular fibrillation (VF) in a patient with Graves’ hyperthyroidism who was later revealed to have a rare SCN5A mutation associated with Brugada syndrome (BrS).
No takes yet. Share an insight, caveat, or question.
Stawiarski et al. (2020) conducted a case report in Graves disease and Ventricular Fibrillation (n=1). Graves' hyperthyroidism and SCN5A mutation (W1191X) was evaluated on Ventricular fibrillation and genetic diagnosis. A 55-year-old woman with Graves' hyperthyroidism experienced ventricular fibrillation and was found to have a rare SCN5A mutation (W1191X) associated with Brugada syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: